Feng Lü

712 total citations
13 papers, 502 citations indexed

About

Feng Lü is a scholar working on Pharmacology, Molecular Biology and Pharmacology. According to data from OpenAlex, Feng Lü has authored 13 papers receiving a total of 502 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Pharmacology, 3 papers in Molecular Biology and 2 papers in Pharmacology. Recurrent topics in Feng Lü's work include Ginger and Zingiberaceae research (2 papers), Pharmacological Effects of Natural Compounds (2 papers) and Medicinal Plants and Neuroprotection (1 paper). Feng Lü is often cited by papers focused on Ginger and Zingiberaceae research (2 papers), Pharmacological Effects of Natural Compounds (2 papers) and Medicinal Plants and Neuroprotection (1 paper). Feng Lü collaborates with scholars based in China, United States and Israel. Feng Lü's co-authors include Chunjie Wu, Rong Zhao, Wei Peng, Mengmeng Zhang, Li Wang, Dan Wang, Qing Zhang, Shujun Wei, Shimon Meir and Cai‐Zhong Jiang and has published in prestigious journals such as Journal of Experimental Botany, Frontiers in Pharmacology and Current Pharmaceutical Design.

In The Last Decade

Feng Lü

12 papers receiving 495 citations

Peers

Feng Lü
Feng Lü
Citations per year, relative to Feng Lü Feng Lü (= 1×) peers Xiankuo Yu

Countries citing papers authored by Feng Lü

Since Specialization
Citations

This map shows the geographic impact of Feng Lü's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Feng Lü with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Feng Lü more than expected).

Fields of papers citing papers by Feng Lü

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Feng Lü. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Feng Lü. The network helps show where Feng Lü may publish in the future.

Co-authorship network of co-authors of Feng Lü

This figure shows the co-authorship network connecting the top 25 collaborators of Feng Lü. A scholar is included among the top collaborators of Feng Lü based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Feng Lü. Feng Lü is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
Lü, Feng, et al.. (2025). Silencing PsASH2 affects embryo development in the cotton mealybug. Insect Molecular Biology. 34(5). 753–762.
2.
Li, Ruolan, Feng Lü, Liying He, et al.. (2022). Development and in vivo Evaluation of Hydroxy-α-Sanshool Intranasal Liposomes as a Potential Remedial Treatment for Alzheimer’s Disease. Dove Medical Press (Taylor and Francis Group). 22 indexed citations
3.
Wang, Dan, Feng Lü, Shuiqing Li, et al.. (2022). Discovery of Active Ingredients in Traditional Chinese Medicine Based on the Analysisof Odor and Flavor of Compounds. Current Pharmaceutical Design. 28(34). 2771–2784. 7 indexed citations
4.
He, Liying, Mei-Bian Hu, Ruolan Li, et al.. (2021). Natural Medicines for the Treatment of Epilepsy: Bioactive Components, Pharmacology and Mechanism. Frontiers in Pharmacology. 12. 604040–604040. 37 indexed citations
5.
Lü, Feng, et al.. (2021). Current strategies and technologies for finding drug targets of active components from traditional Chinese medicine. Frontiers in Bioscience-Landmark. 26(9). 572–589. 31 indexed citations
6.
Zhang, Mengmeng, Dan Wang, Feng Lü, et al.. (2021). Identification of the active substances and mechanisms of ginger for the treatment of colon cancer based on network pharmacology and molecular docking. BioData Mining. 14(1). 1–1. 86 indexed citations
7.
Li, Ruolan, Liying He, Qing Zhang, et al.. (2020). <p>HIF-1α is a Potential Molecular Target for Herbal Medicine to Treat Diseases</p>. Drug Design Development and Therapy. Volume 14. 4915–4949. 19 indexed citations
8.
Zhang, Mengmeng, Rong Zhao, Dan Wang, et al.. (2020). Ginger (Zingiber officinaleRosc.) and its bioactive components are potential resources for health beneficial agents. Phytotherapy Research. 35(2). 711–742. 149 indexed citations
9.
Lü, Feng, Li Cui, Yang Yu, et al.. (2019). [KLF3 regulates the movement, migration and invasion of breast cancer cells through STAT3].. PubMed. 99(38). 3014–3018. 2 indexed citations
10.
Li, Jun, Lina Hu, Chao Tian, et al.. (2015). microRNA-150 promotes cervical cancer cell growth and survival by targeting FOXO4. BMC Molecular Biology. 16(1). 24–24. 62 indexed citations
11.
Lü, Feng, et al.. (2012). Geographic location of antineoplastic agent clinical trials conducted in developed and developing countries. International Journal of Clinical Pharmacy. 35(1). 87–91. 3 indexed citations
12.
Jiang, Cai‐Zhong, Feng Lü, Wachiraya Imsabai, Shimon Meir, & Michael S. Reid. (2008). Silencing polygalacturonase expression inhibits tomato petiole abscission. Journal of Experimental Botany. 59(4). 973–979. 80 indexed citations
13.
Gao, Jianhua, et al.. (2007). [Cell biological study of adipose-derived stem cells].. PubMed. 27(4). 518–23. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026